Tokenizing clinical development data is an efficient way to link them with real-world data. Explore the advantages and challenges of data tokenization.
Follow the story of MMS Holdings, a CRO that launched an adaptive trial that has undergone 22 midstudy changes to date with minimal disruptions across 30,000 subjects and 22 sites.
Clinical trials are critical for cancer patients, but they can be difficult to build and run because of their complexity. See how Zelta helps clients tackle complex oncology trials.
Whether you prefer self-service or full-service solutions, Zelta offers training, study builds, and additional resources to help you overcome common challenges in clinical trials.
